October 22, 2014
Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and healthcare...
More October 08, 2014
Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare Growing importance of drug delivery and dosage devices in Western...
More October 08, 2014
Revenues up 2.2% to EUR 323.9m (+3.2% at constant exchange rates) Adjusted EBITDA with slight improvement on prior-year quarter at EUR 62.1m Net income...
More July 10, 2014
Revenues up 2.6% to EUR 335.4m (6.0% at constant exchange rates) Adjusted EBITDA rises 9.1% to EUR 65.1m (14.1% at constant exchange rates) Net income grows...
More April 30, 2014
Dividend raised to EUR 0.70 per share Management Board and Supervisory Board given formal approval by large majority Dr. Axel Herberg new member of the...
More March 10, 2014
Düsseldorf/Peachtree City (Georgia/USA), March 10, 2014 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, is...
More October 02, 2013
Third-quarter revenues up 1.8% (+4.5% excluding exchange rate effects), to EUR 316.9m Adjusted EBITDA reaches EUR 61.6m (prior-year quarter: EUR 61.6m) Net...
More April 18, 2013
Düsseldorf, April 18, 2013 – A dividend of EUR 0.65 per share was approved at the Annual General Meeting of Gerresheimer AG held today in Düsseldorf. The...
More April 16, 2013
Production of components for a further Sanofi insulin pen Düsseldorf, April 16, 2013. Gerresheimer has commenced production of components for another insulin...
More April 10, 2013
First-quarter revenues up 10.4% to EUR 296.7m Adjusted EBITDA margin reaches 15.5% Net income grows by 41.7% to EUR 10.2m Adjusted earnings per share...
More 